Key statistics
On Thursday, VivoSim Labs Inc (VIVS:NAQ) closed at 1.88, 33.33% above the 52 week low of 1.41 set on Jun 18, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.86 |
|---|---|
| High | 1.95 |
| Low | 1.86 |
| Bid | -- |
| Offer | -- |
| Previous close | 1.87 |
| Average volume | 110.64k |
|---|---|
| Shares outstanding | 2.61m |
| Free float | 2.55m |
| P/E (TTM) | 1.76 |
| Market cap | 4.90m USD |
| EPS (TTM) | 1.07 USD |
Data delayed at least 15 minutes, as of Mar 05 2026 21:00 GMT.
More ▼
- VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
- VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego
- VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
- VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
- VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer
- VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference
- VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference
- VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market
- Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
- Organovo Provides Business Update
More ▼
